Marketplace®
Every story is an economic story

India rejects Novartis cancer drug patent

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment called Gleevec — spelled Glivec in some markets. The decision is expected to have a big impact on pharmaceutical companies and health organizations far outside the borders of India.

The BBC’s Rahul Tandon joins Marketplace Morning Report host Jeremy Hobson to discuss the global pharmaceutical market and the new patent ruling.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    2 days ago
    25:28
  • Marketplace Morning Report
    3 days ago
    6:39
  • Marketplace Tech
    3 days ago
    13:02
  • This Is Uncomfortable
    4 days ago
    42:59
  • Million Bazillion
    13 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33